1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Rapid Test Kit Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Rapid Test Kit Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Rapid Test Kit Market Regional Analysis
6.2 North America Rapid Test Kit Market Revenue 2020-2030 (US$ Million)
6.3 North America Rapid Test Kit Market Forecast Analysis
7. North America Rapid Test Kit Market Analysis – by Type
7.1 Rapid Antigen Testing
- 7.1.1 Overview
- 7.1.2 Rapid Antigen Testing: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Rapid Antibody Testing
- 7.2.1 Overview
- 7.2.2 Rapid Antibody Testing: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
8. North America Rapid Test Kit Market Analysis – by Product
8.1 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit
- 8.1.1 Overview
- 8.1.2 Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
9. North America Rapid Test Kit Market Analysis – by Application
9.1 Blood Glucose Testing
- 9.1.1 Overview
- 9.1.2 Blood Glucose Testing: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Infectious Disease Testing
- 9.2.1 Overview
- 9.2.2 Infectious Disease Testing: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Pregnancy and Fertility
- 9.3.1 Overview
- 9.3.2 Pregnancy and Fertility: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Cardiometabolic Testing
- 9.4.1 Overview
- 9.4.2 Cardiometabolic Testing: North America Rapid Test Kit Market – Revenue and Forecast, 2020-2030 (US$ Million)
10. North America Rapid Test Kit Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Rapid Test Kit Market Breakdown, by Key
Country, 2023 and 2030 (%)
- 10.2.1.1 North America Rapid Test Kit Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.1.1 US: North America Rapid Test Kit Market Breakdown, by Type
- 10.2.1.1.2 US: North America Rapid Test Kit Market Breakdown, by Product
- 10.2.1.1.3 US: North America Rapid Test Kit Market Breakdown, by Application
- 10.2.1.2 Canada:
North America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.2.1 Canada: North America Rapid Test Kit Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Rapid Test Kit Market Breakdown, by Product
- 10.2.1.2.3 Canada: North America Rapid Test Kit Market Breakdown, by Application
- 10.2.1.3 Mexico :
North America Rapid Test Kit Market – Revenue and Forecast to 2030 (US$ Million)
- 10.2.1.3.1 Mexico : North America Rapid Test Kit Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Rapid Test Kit Market Breakdown, by Product
- 10.2.1.3.3 Mexico : North America Rapid Test Kit Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 F. Hoffmann-La Roche Ltd
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Becton Dickinson and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 ARKRAY Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Fujirebio Europe NV
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 bioMerieux SA
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Cepheid
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Meril Life Sciences Pvt Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 QIAGEN NV
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 OraSure Technologies Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Guangzhou Wondfo Biotech Co Ltd
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
13.11 Denka Co Ltd
- 13.11.1 Key Facts
- 13.11.2 Business Description
- 13.11.3 Products and Services
- 13.11.4 Financial Overview
- 13.11.5 SWOT Analysis
- 13.11.6 Key Developments
13.12 Abbott Laboratories
- 13.12.1 Key Facts
- 13.12.2 Business Description
- 13.12.3 Products and Services
- 13.12.4 Financial Overview
- 13.12.5 SWOT Analysis
- 13.12.6 Key Developments
13.13 Trinity Biotech Plc
- 13.13.1 Key Facts
- 13.13.2 Business Description
- 13.13.3 Products and Services
- 13.13.4 Financial Overview
- 13.13.5 SWOT Analysis
- 13.13.6 Key Developments
13.14 SD Biosensor Inc
- 13.14.1 Key Facts
- 13.14.2 Business Description
- 13.14.3 Products and Services
- 13.14.4 Financial Overview
- 13.14.5 SWOT Analysis
- 13.14.6 Key Developments
13.15 Bio-Rad Laboratories Inc
- 13.15.1 Key Facts
- 13.15.2 Business Description
- 13.15.3 Products and Services
- 13.15.4 Financial Overview
- 13.15.5 SWOT Analysis
- 13.15.6 Key Developments
13.16 Hologic Inc
- 13.16.1 Key Facts
- 13.16.2 Business Description
- 13.16.3 Products and Services
- 13.16.4 Financial Overview
- 13.16.5 SWOT Analysis
- 13.16.6 Key Developments
13.17 DiaSorin SpA
- 13.17.1 Key Facts
- 13.17.2 Business Description
- 13.17.3 Products and Services
- 13.17.4 Financial Overview
- 13.17.5 SWOT Analysis
- 13.17.6 Key Developments
13.18 Beckman Coulter Inc
- 13.18.1 Key Facts
- 13.18.2 Business Description
- 13.18.3 Products and Services
- 13.18.4 Financial Overview
- 13.18.5 SWOT Analysis
- 13.18.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations